138 related articles for article (PubMed ID: 1713932)
1. Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
Damjanović S; Micić D; Popović V; Petakov M; Kendereski A; Sumarac M; Manojlović D; Mićić J
J Endocrinol Invest; 1991 Apr; 14(4):299-304. PubMed ID: 1713932
[TBL] [Abstract][Full Text] [Related]
2. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
Popovic V; Damjanovic S
Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
[TBL] [Abstract][Full Text] [Related]
3. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of insulin-like growth factor 1 on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas.
Atkin SL; Landolt AM; Jeffreys RV; Hipkin L; Radcliffe J; Squire CR; White MC
J Clin Endocrinol Metab; 1993 Oct; 77(4):1059-66. PubMed ID: 7691862
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone.
Winters SJ; Ishizaka K; Kitahara S; Troen P; Attardi B
Endocrinology; 1992 Feb; 130(2):726-34. PubMed ID: 1370794
[TBL] [Abstract][Full Text] [Related]
9. Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum alpha-subunit levels.
Borges JL; Ridgway EC; Kovacs K; Rogol AD; Thorner MO
J Clin Endocrinol Metab; 1984 May; 58(5):937-41. PubMed ID: 6200493
[TBL] [Abstract][Full Text] [Related]
10. Prolonged treatment with the GnRH analogue buserelin does not affect alpha-subunit production by the pituitary gonadotroph.
Kwekkeboom DJ; Lamberts SW; Blom JH; Schroeder FH; De Jong FH
Clin Endocrinol (Oxf); 1990 Apr; 32(4):443-51. PubMed ID: 1693322
[TBL] [Abstract][Full Text] [Related]
11. Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
Chapman AJ; MacFarlane IA; Shalet SM; Beardwell CG; Dutton J; Sutton ML
Clin Endocrinol (Oxf); 1984 Aug; 21(2):123-9. PubMed ID: 6205794
[TBL] [Abstract][Full Text] [Related]
12. Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
Damjanović SS; Popović VP; Petakov MS; Nikolic-Durović MM; Doknić MZ; Gligorović MS
J Endocrinol Invest; 1996 Nov; 19(10):663-9. PubMed ID: 9007697
[TBL] [Abstract][Full Text] [Related]
13. Dissociated effect of buserelin on luteinizing hormone (LH) and alpha subunit in men.
Valenti G; Denti L; Banchini A; Ceresini G; Ceda GP; Westel WC; Negro-Vilar A
J Endocrinol Invest; 1990 Jun; 13(6):459-67. PubMed ID: 1701778
[TBL] [Abstract][Full Text] [Related]
14. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology.
Cunningham GR; Huckins C
J Clin Endocrinol Metab; 1977 Feb; 44(2):248-53. PubMed ID: 402377
[TBL] [Abstract][Full Text] [Related]
15. Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release.
Medri G; Carella C; Padmanabhan V; Rossi CM; Amato G; De Santo NG; Beitins IZ; Beck-Peccoz P
J Endocrinol Invest; 1993 Mar; 16(3):169-74. PubMed ID: 7685785
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
17. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma.
Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232
[TBL] [Abstract][Full Text] [Related]
18. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone.
Surmont DW; Winslow CL; Loizou M; White MC; Adams EF; Mashiter K
Clin Endocrinol (Oxf); 1983 Sep; 19(3):325-36. PubMed ID: 6194923
[TBL] [Abstract][Full Text] [Related]
20. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
